Related Experiment Videos

American Academy of Pediatrics: Maternal phenylketonuria

    Pediatrics
    |February 7, 2001
    PubMed

    Insights

    High maternal phenylalanine levels during pregnancy cause birth defects. Early counseling and strict metabolic control before and during pregnancy are crucial for preventing adverse fetal effects in phenylketonuria.

    Area of Science:

    • Maternal-fetal medicine
    • Metabolic disorders
    • Teratology

    Background:

    • Elevated maternal phenylalanine is teratogenic, causing fetal growth retardation, psychomotor handicaps, and birth defects in untreated pregnancies.
    • Phenylketonuria (PKU) and hyperphenylalaninemia require careful management in women of childbearing age.
    • Adverse fetal outcomes are linked to unmonitored and untreated maternal metabolic imbalances.

    Framework:

    • Preconception counseling is vital for women with PKU and related disorders.
    • Risk assessment for adverse fetal effects should be conducted before conception.
    • Optimal management involves understanding the teratogenic risks of maternal hyperphenylalaninemia.

    Implementation:

    • Women of childbearing age with all forms of phenylketonuria should receive counseling.
    • Counseling should focus on the risks of adverse fetal effects.
    • Management strategies should be initiated optimally before conception.

    Implications:

    • Strict control of maternal phenylalanine levels before and during pregnancy improves fetal outcomes.
    • Early and continuous metabolic control minimizes the risk of developmental issues in offspring.
    • Proactive management of maternal metabolic health is essential for preventing congenital abnormalities.

    Related Concept Videos